BARBARA ANN KARMANOS CANCER INSTITUTE

BARBARA ANN KARMANOS CANCER INSTITUTE logo
🇺🇸United States
Ownership
Private
Established
1995-01-01
Employees
5K
Market Cap
-
Website
http://www.karmanos.org

Monoclonal Antibody Therapy in Treating Patients With Advanced Solid Tumors

First Posted Date
2003-01-27
Last Posted Date
2014-01-16
Lead Sponsor
Barbara Ann Karmanos Cancer Institute
Registration Number
NCT00052403

XK469 in Treating Patients With Advanced Solid Tumors

First Posted Date
2003-01-27
Last Posted Date
2014-04-25
Lead Sponsor
Barbara Ann Karmanos Cancer Institute
Target Recruit Count
22
Registration Number
NCT00028548
Locations
🇺🇸

Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, United States

Bryostatin 1 Plus Cladribine in Treating Patients With Relapsed Chronic Lymphocytic Leukemia

Phase 1
Completed
Conditions
First Posted Date
2003-01-27
Last Posted Date
2014-04-24
Lead Sponsor
Barbara Ann Karmanos Cancer Institute
Target Recruit Count
80
Registration Number
NCT00003174
Locations
🇺🇸

Josephine Ford Cancer Center at Henry Ford Hospital, Detroit, Michigan, United States

🇺🇸

Van Elslander Cancer Center at St. John Hospital and Medical Center, Grosse Pointe Woods, Michigan, United States

🇺🇸

Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, United States

Biological Therapy in Treating Women With Stage IV Breast Cancer

First Posted Date
2003-01-27
Last Posted Date
2016-02-17
Lead Sponsor
Barbara Ann Karmanos Cancer Institute
Target Recruit Count
6
Registration Number
NCT00027807
Locations
🇺🇸

Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, United States

© Copyright 2024. All Rights Reserved by MedPath